| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 02/09/2012 | WO2012018059A1 Heterocyclic compound |
| 02/09/2012 | WO2012017449A1 Process for preparation of novel 42-0-(heteroalkoxyalkyl) rapamycin compounds with anti-proliferative properties" |
| 02/09/2012 | US20120035409 Bi- and tricyclic indazole-substituted 1,4-dihydropyridine derivatives and uses thereof |
| 02/08/2012 | EP2414340A1 Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof |
| 02/08/2012 | EP2414334A1 Bridged bicyclic heterocycle derivatives and methods of use thereof |
| 02/08/2012 | EP2414331A1 5-ht receptor modulating compounds |
| 02/08/2012 | EP1633365B1 Macrocyclic quinazoline derivatives as antiproliferative agents |
| 02/08/2012 | CN1934091B 治疗神经变性障碍的咪唑化合物 Treatment of neurodegenerative disorders imidazole compound |
| 02/08/2012 | CN102348698A Inhibitors of beta-secretase |
| 02/08/2012 | CN102344457A Spirocyclic aminoquinolones as gsk-3 inhibitors |
| 02/02/2012 | WO2012015693A1 Imidazole derivatives |
| 02/02/2012 | WO2012013557A1 Isoxazolo-quinazolines as modulators of protein kinase activity |
| 02/02/2012 | US20120029192 Pyrazole Derivatives |
| 02/02/2012 | US20120029190 Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof |
| 02/02/2012 | US20120028973 Nitroimidazooxazines and their uses in anti-tubercular therapy |
| 02/02/2012 | US20120028969 Bicyclic acetyl-coa carboxylase inhibitors and uses thereof |
| 02/02/2012 | US20120028939 Substituted naphthyridines and their use as medicaments |
| 02/02/2012 | US20120028908 Methods of Manufacturing Crystalline Forms of Rapamycin Analogs |
| 02/02/2012 | US20120027852 Pharmaceutical composition containing a "limus" family immunosuppressive macrolide |
| 02/01/2012 | EP2412710A1 Fused piperidine compound and pharmaceutical agent comprising same |
| 02/01/2012 | EP2411365A1 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds |
| 02/01/2012 | EP2411012A1 Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 02/01/2012 | EP2410854A2 Substituted 1, 4-dioxa-8-azaspiro ý4,5¨decanes useful as fungicides and a process for the preparation thereof |
| 02/01/2012 | EP2410844A1 Inhibitors of hepatitis c virus replication |
| 02/01/2012 | EP2265601B1 Pyridazine derivatives as factor xia inhibitors |
| 02/01/2012 | EP2130827B1 Method for producing quinolone carboxylic acid derivative |
| 02/01/2012 | EP2078016B1 Heteroaryl compounds, compositions thereof, and methods of treatment therewith |
| 02/01/2012 | EP1888595B1 Spiro-oxindole compounds and their uses as therapeutic agents |
| 02/01/2012 | CN102341394A Poly (ADP-Ribose) Polymerase (PARP) Inhibitors |
| 02/01/2012 | CN102336769A Simple and novel method for synthesizing spiro[oxoindole-3,5'-oxazoline] heterocyclic compound |
| 02/01/2012 | CN101622259B 作为nk3拮抗剂的螺哌啶衍生物 As nk3 antagonists spiro piperidine derivative |
| 01/31/2012 | US8106213 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 01/31/2012 | US8106201 Process for the synthesis of morphinane compounds and intermediates thereof |
| 01/31/2012 | US8106050 Derivatives of pyrrolo-pyrazines having a kinase inhibitory activity and their biological applications |
| 01/26/2012 | WO2012012391A2 Process for preparing pyrano - [2,3-c]pyridine derivatives |
| 01/26/2012 | WO2012010704A1 New aminopyrazoloquinazolines |
| 01/26/2012 | WO2012010663A1 2,3,5-trisubstituted thiophene compounds and uses thereof |
| 01/26/2012 | WO2012010633A1 Herbicidal isoxazolo[5,4-b]pyridines |
| 01/26/2012 | US20120022251 Method of producing pyrone and pyridone derivatives |
| 01/26/2012 | US20120022056 Fused tricyclic derivatives for the treatment of psychotic disorders |
| 01/26/2012 | US20120022053 Oxadiazine Derivatives |
| 01/26/2012 | US20120021897 Ring compound |
| 01/26/2012 | US20120021007 Nitric oxide furoxan derivative compounds endowed with antitumoral activity |
| 01/26/2012 | US20120018687 Process for the preparation of easily dispersible Violet Pigment |
| 01/26/2012 | CA2806108A1 2,3,5-trisubstituted thiophene compounds and uses thereof |
| 01/26/2012 | CA2805354A1 Herbicidal isoxazolo[5,4-b]pyridines |
| 01/26/2012 | CA2803467A1 New aminopyrazoloquinazolines |
| 01/25/2012 | EP2408766A1 Bicyclic compounds as inhibitors of diacylglycerol acyltransferase |
| 01/25/2012 | EP1660458B1 2, 4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 01/25/2012 | CN1558759B 病毒聚合酶抑制剂 Viral polymerase inhibitors |
| 01/25/2012 | CN102333782A Spiro azepane-oxazolidinones as kv1.3 potassium channel blockers |
| 01/25/2012 | CN102333777A Nitrogen-containing fused heterocyclic compounds and their use as beta amyloid production inhibitors |
| 01/25/2012 | CN102333773A Mineralocorticoid receptor antagonist and methods of use |
| 01/25/2012 | CN101418003B 5-aryl-9-alkyl-4,6-dioxo-1-aza-bicyclo[3.3.1]nonane hydrochloride and preparation method thereof |
| 01/24/2012 | US8101637 Alkynyl derivatives as modulators of metatropic glutamate receptors |
| 01/24/2012 | CA2642211C 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases |
| 01/24/2012 | CA2494340C Compounds with the bicyclo[4.2.1]nonane system for the treatment of flaviviridae infections |
| 01/19/2012 | WO2012009388A1 Formulations of rifaximin and uses thereof |
| 01/19/2012 | WO2012009387A1 Formulations of rifaximin and uses thereof |
| 01/19/2012 | WO2012009309A1 Compounds for the reduction of beta-amyloid production |
| 01/19/2012 | WO2011138751A3 Heterocyclic derivatives as alk inhibitors |
| 01/19/2012 | WO2011092564A4 Process for the preparation of temsirolimus and its intermediates |
| 01/19/2012 | US20120015971 Ophthalmic composition comprising ascomycin |
| 01/19/2012 | US20120015940 Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 01/19/2012 | US20120015933 Spirocyclic nitriles as protease inhibitors |
| 01/19/2012 | US20120015930 Substituted imidazoheterocycle derivatives |
| 01/19/2012 | US20120015928 Amido Compounds And Their Use As Pharmaceuticals |
| 01/19/2012 | US20120015907 Furopyridine compounds and uses thereof |
| 01/19/2012 | CA2805294A1 Compounds for the reduction of beta-amyloid production |
| 01/19/2012 | CA2804970A1 Spirocyclic compounds |
| 01/19/2012 | CA2804635A1 Formulations of rifaximin and uses thereof |
| 01/18/2012 | EP2407473A2 Method for producing phosphorus-containing compounds |
| 01/18/2012 | EP2407471A2 Process for preparing a crystalline form of rapamycin analogs |
| 01/18/2012 | EP2406266A1 7-cycloalkylaminoquinolones as gsk-3 inhibitors |
| 01/18/2012 | EP2406265A2 Substituted 3-aminoisoxazolopyridines as kcnq2/3 modulators |
| 01/18/2012 | EP2406252A1 Mineralocorticoid receptor antagonist and methods of use |
| 01/18/2012 | EP2406240A2 Inhibitors of beta-secretase |
| 01/18/2012 | EP2310395B1 9-substituted-b-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials |
| 01/18/2012 | CN102325772A Ring compound |
| 01/18/2012 | CN102325764A Pyrimidine indole derivatives for treating cancer |
| 01/18/2012 | CN102320976A Cyclic carbodiimide compounds |
| 01/17/2012 | US8097730 Bicyclic heterocycles useful as selective androgen receptor modulators |
| 01/17/2012 | US8097628 Compounds |
| 01/17/2012 | US8097607 loading-dose regimen; an initial administration of rifalazil for 4 to 14 days, followed by less than half this average daily dose for the subsequent 4 to 14 days |
| 01/17/2012 | CA2558139C Tricyclic benzopyran compound as anti-arrhythmic agents |
| 01/17/2012 | CA2484640C Vitamin-mitomycin conjugates |
| 01/12/2012 | WO2012006104A2 Compounds and methods for treating tuberculosis infection |
| 01/12/2012 | WO2012004400A1 Novel spiroheterocyclic compounds as mglu5 antagonists |
| 01/12/2012 | WO2012004373A1 Fused heterocyclic derivatives as s1p modulators |
| 01/12/2012 | WO2011112731A3 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| 01/12/2012 | WO2010135524A8 Benzoxazepines based p13k/mt0r inhibitors against proliferative diseases |
| 01/12/2012 | US20120010404 Oxazine dyes with improved aqueous solubility |
| 01/12/2012 | US20120010402 CGRP Receptor Antagonists |
| 01/12/2012 | US20120010193 Cgrp receptor antagonists |
| 01/12/2012 | CA2804940A1 Process for the synthesis of substituted morphinans |
| 01/12/2012 | CA2804137A1 Fused heterocyclic derivatives as s1p modulators |
| 01/12/2012 | CA2800930A1 Novel spiroheterocyclic compounds as mglu5 antagonists |
| 01/11/2012 | EP2404922A1 Quinoxaline compounds |
| 01/11/2012 | EP1991549B1 Bicyclic imidazole or thiadiazole heterocycles useful as selective androgen receptor modulators |
| 01/11/2012 | EP1945647B1 Processes for preparation of maytansinol |